Manchester Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Manchester Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-700	Closed	-$49K	–	651
2015 Q4	$49K	Hold	700	–	–	0.01%	449
2015 Q3	$46K	Hold	700	–	–	0.01%	439
2015 Q2	$55K	Hold	700	–	–	0.01%	377
2015 Q1	$53K	Hold	700	–	–	0.01%	362
2014 Q4	$47K	Buy	+700	New	+$46.6K	0.01%	731

Other funds holding PJP

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SCM

Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

Manchester Capital Management's PJP Position: Q1 2016 in Review

Manchester Capital Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2016, closing a stake of 700 shares — an estimated $49K sold.

Manchester Capital Management first reported a position in PJP in Q4 2014 and held it in 5 quarters. The position peaked at $55K in Q2 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2016.

Manchester Capital Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
Manchester Capital Management sold 700 Invesco Pharmaceuticals ETF shares in Q1 2016, an estimated $49K.
Manchester Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2014 and held it in 5 quarters.
Manchester Capital Management's Invesco Pharmaceuticals ETF position peaked at $55K in Q2 2015.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2016.

Based on Manchester Capital Management's 13F filing for Q1 2016, filed 4 May 2016.